中长期科技创新债券
Search documents
金融活水润绿能
Jing Ji Ri Bao· 2025-12-02 22:09
近年来,甘肃省金融系统紧紧围绕降碳增效目标,推动绿色金融提质增效。在机制创新上,构建人民银 行、政府部门、金融机构"三位一体"的融资对接长效机制,推动368个绿色项目获得授信3628.58亿元。 各市州结合本地实际积极开展创新实践,嘉峪关市发行全省首笔中长期科技创新债券5亿元,张掖市发 放首笔"水权贷"500万元,平凉市推出"碳减排量+产品碳足迹"双挂钩贷款180万元,形成了多层次、多 样化的绿色金融服务体系。 近日,甘肃省兰州市东城区清洁智慧热源项目的建设工地一派忙碌景象。该项目是兰州市重点新能源热 源项目之一,利用酒钢集团榆中钢铁有限责任公司生产废热进行供热,由河海新能源(兰州)有限公司 投资建设运营。项目建成后每年节约12.3万吨标准煤,减少32.2万吨二氧化碳排放。 "我们将钢铁厂的低温水,通过磁悬浮离心热泵梯级提温后,进入供热管网进行供热,1期项目已具备 1000万平方米的供热能力。目前,实际供热面积600万平方米。"河海新能源(兰州)有限公司总经理王 全胜介绍。 该项目的顺利推进,离不开金融创新的有力支撑。今年,兰州银行创新运用人民银行碳减排支持工具, 为项目量身定制了"绿色贷款+碳减排支持工具" ...
创新转型获认可 复星医药成功发行10亿元中长期科技创新债券
Zheng Quan Ri Bao· 2025-08-15 05:13
Group 1 - Shanghai Fosun Pharmaceutical Group Co., Ltd. successfully issued the first private pharmaceutical industry medium to long-term technology innovation bond in China, with a scale of 1 billion RMB and a maturity of 2 years at a coupon rate of 2.70% [2] - The bond received enthusiastic subscriptions from various financial institutions, including bank wealth management, insurance, foreign banks, public funds, and securities firms [2] - The successful issuance of the technology innovation bond further consolidates Fosun Pharma's leading position among domestic innovative pharmaceutical companies and supports the company's high-quality development [3] Group 2 - Fosun Pharma has been driven by innovation for over 30 years, having approved 12 self-developed and licensed innovative drugs and biosimilars since 2019 [3] - The company has secured commercial rights for 8 innovative drugs in China, covering key treatment areas such as solid tumors, hematological tumors, and immune inflammation [3] - Fosun Pharma aims to deepen its innovation transformation and provide better and more accessible products and services for patients and clients, while creating sustainable value returns for shareholders [3]